Lidia S. Foteeva - Concepedia

Author

Lidia S. Foteeva

V.I. Vernadsky Institute of Geochemistry and Analytical Chemistry ORCID

Also Known As

L. S. Foteeva, L.S. Foteeva, Lidia S. Foteeva

Publications

567

Citations

H-Index

Concepts

All Affiliations

V.I. Vernadsky Institute of Geochemistry and Analytical Chemistry Russian Academy of Sciences University of Vienna Warsaw University of Technology Lomonosov Moscow State University

About

Lidia S. Foteeva is an author at V.I. Vernadsky Institute of Geochemistry and Analytical Chemistry specializing in biochemistry, medicine, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	12	401
2	Biochemistry	11	11	377
3	Natural Sciences	8	8	297
4	Engineering	2	2	57
5	Biomolecular Engineering	2	2	57

Lidia S. Foteeva

Publications

469

Citations

H-Index

Page 1

	Year	Citations
Preclinical characterization of anticancer gallium(III) complexes: Solubility, stability, lipophilicity and binding to serum proteins Alexander V. Rudnev, Lidia S. Foteeva, Christian R. Kowol, Journal of Inorganic Biochemistry Medicinal ChemistryBiochemistryMedicineNatural SciencesPreclinical Characterization	2006	109
Application of capillary electrophoresis–inductively coupled plasma mass spectrometry to comparative studying of the reactivity of antitumor ruthenium(III) complexes differing in the nature of counter-ion toward human serum proteins Jan K. Abramski, Julia Ferenc, Lidia S. Foteeva, Journal of Chromatography A Human Serum ProteinsMedicinal ChemistryBiochemistryAntitumor RutheniumMedicine	2008	49
Probing the stability of serum protein–ruthenium(III) drug adducts in the presence of extracellular reductants using CE Andrei R. Timerbaev, Lidia S. Foteeva, Alexander V. Rudnev, Electrophoresis Pharmaceutical ScienceChemoprevention StrategyExtracellular ReductantsRedox BiologyOxidative Stress	2007	46
Metallomics for drug development: an integrated CE-ICP-MS and ICP-MS approach reveals the speciation changes for an investigational ruthenium(iii) drug bound to holo-transferrin in simulated cancer cytosol Svetlana S. Aleksenko, Magdalena Matczuk, Xifeng Lu, Metallomics EngineeringRedox BiologyRuthenium IonDrug BoundMedicinal Chemistry	2013	40
Enhancing the Cytotoxic Activity of Anticancer Pt<sup>IV</sup> Complexes by Introduction of Lonidamine as an Axial Ligand Yulia N. Nosova, Lidia S. Foteeva, Timur I. Fetisov, European Journal of Inorganic Chemistry Pt Iv ComplexesLog PCytotoxic ActivityMedicinal ChemistryAxial Ligand	2016	38
Determination of gallium originated from a gallium-based anticancer drug in human urine using ICP-MS Darya Filatova, Lidia S. Foteeva, V. V. Pukhov, Analytical and Bioanalytical Chemistry UrologyMedicineBioanalysisMass SpectrometryAnalytical Chemistry	2011	24
A versatile approach for assaying in vitro metallodrug metabolism using CE hyphenated with ICP-MS Jan K. Abramski, Lidia S. Foteeva, Andrei R. Timerbaev, The Analyst BioanalysisPlasma Mass SpectrometryAnalytical ChemistryLiquid ChromatographyClinical Chemistry	2009	23
Combination of ICP-MS, capillary electrophoresis, and their hyphenation for probing Ru(III) metallodrug–DNA interactions Lidia S. Foteeva, Magdalena Matczuk, Katarzyna Pawlak, Analytical and Bioanalytical Chemistry	2017	21
Focusing of anionic micelles using sample‐induced transient isotachophoresis: Computer simulation and experimental verification in MEKC Lidia S. Foteeva, Zhuo Huang, Andrei R. Timerbaev, Journal of Separation Science	2010	18
Application of micellar and microemulsion electrokinetic chromatography for characterization of gallium(III) complexes of pharmaceutical significance Andrei R. Timerbaev, Oksana O. Vasylenko, Lidia S. Foteeva, Journal of Separation Science	2007	18

Page 1